No­var­tis de­tails plans to axe 8,000 staffers as Narasimhan be­gins sec­ond phase of a glob­al re­org

We now know the num­ber of jobs com­ing un­der the axe at No­var­tis, and it isn’t small.

The phar­ma gi­ant is con­firm­ing a re­port from Swiss news­pa­per Tages-Anzeiger that it is chop­ping 8,000 jobs out of its 108,000 glob­al staffers. A large seg­ment will hit right at com­pa­ny head­quar­ters in Basel, as CEO Vas Narasimhan ax­es some 1,400 of a lit­tle more than 11,000  jobs in Switzer­land.

The first phase of the work is al­most done, the com­pa­ny says in a state­ment to End­points News. Now it’s on to phase two. In the state­ment, No­var­tis says:

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER